These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 6329638

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Carmine AA, Brogden RN, Heel RC, Romankiewicz JA, Speight TM, Avery GS.
    Drugs; 1983 Oct; 26(4):279-333. PubMed ID: 6354685
    [Abstract] [Full Text] [Related]

  • 11. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL, Foster RH, Benfield P.
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Third-generation cephalosporins: a critical evaluation.
    Barriere SL, Flaherty JF.
    Clin Pharm; 1984 Jan; 3(4):351-73. PubMed ID: 6432420
    [Abstract] [Full Text] [Related]

  • 14. Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Barradell LB, Bryson HM.
    Drugs; 1994 Mar; 47(3):471-505. PubMed ID: 7514976
    [Abstract] [Full Text] [Related]

  • 15. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A, Richards DM.
    Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.
    Lamb HM, Ormrod D, Scott LJ, Figgitt DP.
    Drugs; 2002 Nov; 62(7):1041-89. PubMed ID: 11985490
    [Abstract] [Full Text] [Related]

  • 18. Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicin.
    Bremner DA.
    Chemotherapy; 1983 Nov; 29(4):283-8. PubMed ID: 6307605
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL, Jacobus NV, Tally FP, Gorbach SL.
    Clin Ther; 1983 Nov; 5(6):603-16. PubMed ID: 6313195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.